Medical Marijuana, Inc. (MJNA) Research

Established in 2005 and based in San Diego, California, Medical Marijuana, Inc. operates as an investment holding entity primarily focused on the cannabinoid-based health and wellness industry. The company specializes in the development, marketing, and global distribution of hemp oils rich in naturally occurring cannabinoids, including CBD, alongside a variety of other non-psychoactive cannabidiol products. It also innovates with cannabis/cannabinoid-infused chewing gum, specifically formulated for the therapeutic management of pain and various other medical conditions. Beyond its core product offerings, the firm commits significant resources to research and development. This includes exploring novel therapeutic agents designed to mitigate oxidative stress, modulate immune responses, and provide neuroprotection. It also offers a comprehensive range of dietary supplements, skincare solutions, and prescription-grade hemp oils, distributed under its well-known Kannaway and HempMeds brands. Furthermore, Medical Marijuana, Inc. implements proprietary methodologies for testing, genetic selection, labeling, packaging, tracking, production, and standardization across the medicinal cannabinoid sector. Its product portfolio extends to include RSHO oil, addressing diverse health concerns, as well as a line of plant-based, non-GMO pet products that cater to animal health, recreation, and environmentally conscious needs.

Open Medical Marijuana, Inc. (MJNA) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.